Oncolytic vaccinia virus delivering targeted CD19 in vivo CAR-T/M therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oncolytic vaccinia virus delivering targeted CD19 in vivo CAR-T/M therapy, covering 2026-02-10 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of Oncolytic Vaccinia VIrus Delivering Targeted CD19 in Vivo CAR-T/M Therapy for Refractory/Relapsed B-cell Lymphoma [Phase 1]